Insider Transactions Reported by 16 Insiders of ADC Therapeutics SA

Symbol
ADCT on NYSE
Location
Epalinges, Switzerland

Insiders trading volume in the past year

ADC Therapeutics SA executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Redmile Group, LLC 10%+ Owner $139,775,400 +$126,780,681 +976% 27 Oct 2025
HANS PETER WILD 10%+ Owner $14,291,858 15 May 2025
AMEET MALLIK Chief Executive Officer, Director $4,339,842 06 Dec 2025
Jose Carmona Chief Financial Officer $1,607,678 06 Dec 2025
Mohamed Zaki Chief Medical Officer $1,387,787 06 Dec 2025
PETER J. GRAHAM Chief Legal Officer $1,181,221 06 Dec 2025
Peter Hug Director $789,390 13 Jun 2025
Viviane Monges Director $515,673 13 Jun 2025
Victor Sandor Director $387,663 13 Jun 2025
JEAN-PIERRE BIZZARI Director $382,709 13 Jun 2025
Ron Squarer Director $335,184 13 Jun 2025
Robert Azelby Director $287,849 13 Jun 2025
Thomas Pfisterer Other* $253,892 15 May 2025
Lisa Kallebo Chief Accounting Officer $232,790 06 Dec 2025
Timothy Coughlin Director $53,600 03 Jun 2025
Tyrell Rivers Director 02 Jan 2024

Recent Insider Transactions by Companies or Individuals for ADC Therapeutics SA

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.